arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Perspective Therapeutics, Inc.

CATX Health Care Medical/Dental Instruments
$1.69
▼ -26.7% Today
as of Oct 23, 14:16 ET
Last 30 days -42.47% Sep 14 → Oct 23
$1.58 $1.95 $2.32 $2.70 $3.07 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$2.25
High
$2.33
Low
$2.22
Volume
$966,296
Avg Vol
$2M
Mkt Cap
$310M
P/E (TTM)
—
Beta
—
52w High
$6.16
52w Low
$1.96
Div Yield
—
Shares Out
$114M

Recent Press Releases & News last 60 days · 10 items

Oct 23 · 16:32 MT Newswires
Perspective Reports 'Encouraging' Bamzireotide Profile in Tumor Trial
Oct 23 · 14:49 PR GlobeNewswire
Perspective’s [212Pb]Bamzireotide Navoxetan (VMT-α-NET) Demonstrates Encouraging Safety, Durable Disease Control, and Robust Tumor Response Across Multiple Dose Cohorts in Phase 1/2a Trial in Advanced SSTR2-Expressing NETs
Oct 8 · 10:53 MT Newswires
Perspective's Cancer Therapy Candidate Receives FDA Fast Track Designation; Shares Rise Pre-Bell
▸ Show all 10 press releases & news Free account →

CATX earnings at a glance

The options market is pricing a move of about ±14.8% after the report, a range of roughly $1.44 to $1.94 from today's $1.69. Over its last 2 reports the stock rose the next day 2 times and fell 0, moving ±5.0% on average; after the most recent report on May 11, 2026 it moved +3.2%. That means options currently expect more movement than CATX has typically delivered. CATX beat the consensus EPS estimate in 2 of its last 4 reported quarters. Implied volatility is currently 112%. The share price of $1.69 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$1.96
$6.16
0% of range
Avg surprise (last 4)
+4.6%
Avg reaction (last 2)
+5.0%
100% positive
Latest IV / EM
112%
EM ±14.8% · $3 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.40$-0.35$-0.29$-0.23$-0.18 Actual $-0.40Actual $-0.37Actual $-0.25Actual $-0.18Actual $-0.21Actual $-0.25Est $-0.28Actual $-0.30Est $-0.30Actual $-0.35Est $-0.33Actual $-0.25Est $-0.29Actual $-0.22 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-27M$-24M$-21M$-19M$-16M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.22 — — — — financials
Mon May 11, 2026Mar/2026 $-0.25 $-0.29 +13.8% 0.0% +3.2% earnings
Mon Nov 10, 2025Sep/2025 $-0.35 $-0.33 -6.1% — — earnings
Wed Aug 13, 2025Jun/2025 $-0.30 $-0.30 0.0% — — earnings
Mon May 12, 2025Mar/2025 $-0.25 $-0.28 +10.7% — +6.8% earnings
Mon Sep 30, 2024Sep 2024 $-0.21 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.18 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.25 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.37 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.40 — — — — financials
Fri Mar 31, 2023Mar 2023 — — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue————————
Cost of revenue————————
Gross profit————————
Operating income$-29M$-28M—$-28M$-24M$-22M—$-19M
Net income$-27M$-26M—$-26M$-21M$-18M—$-15M
EPS (diluted)$-0.22$-0.25—$-0.35$-0.29$-0.25—$-0.21

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$48M$54M$31M$27M$29M$44M$62M$226M
Inventory————————
Total current assets$242M$275M$148M$178M$196M$216M$231M$270M
Total assets$392M$411M$267M$295M$311M$329M$341M$391M
Long-term debt$2M$2M—$2M$2M$2M—$2M
Total liabilities$68M$63M$60M$53M$45M$45M$50M$63M
Total equity$324M$347M$207M$242M$266M$285M$291M$328M

Implied volatility — last 90 days

51%506%961%1416%1871% Jun 07 — IV 953% · EM ±132.0%Jun 08 — IV 129% · EM ±17.1%Jun 09 — IV 80% · EM ±10.0%Jun 10 — IV 1004% · EM ±118.6%Jun 17 — IV 884% · EM ±36.9%Jun 19 — IV 261% · EM ±57.6%Jun 22 — IV 212% · EM ±44.3%Jun 23 — IV 269% · EM ±55.0%Jun 24 — IV 241% · EM ±48.3%Jun 29 — IV 364% · EM ±64.4%Jun 30 — IV 383% · EM ±66.0%Jul 01 — IV 450% · EM ±75.1%Jul 02 — IV 375% · EM ±60.6%Jul 03 — IV 388% · EM ±60.6%Jul 06 — IV 460% · EM ±63.7%Jul 07 — IV 332% · EM ±43.8%Jul 08 — IV 447% · EM ±56.0%Jul 09 — IV 414% · EM ±48.9%Jul 15 — IV 1376% · EM ±81.2%Jul 21 — IV 109% · EM ±25.4%Jul 23 — IV 203% · EM ±45.8%Jul 24 — IV 210% · EM ±46.4%Jul 27 — IV 212% · EM ±44.3%Jul 28 — IV 843% · EM ±172.5%Jul 31 — IV 224% · EM ±43.0%Aug 03 — IV 234% · EM ±41.5%Aug 04 — IV 513% · EM ±88.3%Aug 05 — IV 335% · EM ±56.0%Aug 06 — IV 260% · EM ±42.1%Aug 07 — IV 267% · EM ±41.7%Aug 10 — IV 337% · EM ±46.7%Aug 12 — IV 355% · EM ±44.5%Aug 13 — IV 415% · EM ±49.1%Aug 17 — IV 502% · EM ±41.9%Aug 19 — IV 1871% · EM ±110.5%Aug 25 — IV 238% · EM ±48.6%Aug 27 — IV 265% · EM ±51.9%Sep 01 — IV 290% · EM ±50.0%Sep 02 — IV 280% · EM ±46.8%Sep 04 — IV 274% · EM ±42.9%Sep 07 — IV 311% · EM ±43.1%Sep 09 — IV 334% · EM ±41.8%Sep 21 — IV 234% · EM ±48.8%Sep 22 — IV 231% · EM ±47.3%Sep 23 — IV 110% · EM ±21.9%Sep 24 — IV 51% · EM ±10.0%Sep 25 — IV 98% · EM ±18.8%Sep 28 — IV 56% · EM ±10.0%Sep 29 — IV 199% · EM ±34.4%Sep 30 — IV 206% · EM ±34.4%Oct 06 — IV 112% · EM ±14.8%

Sector peers

EMBC
Embecta Corp.
$310M $6.75+1.0%
CLPT
ClearPoint Neuro Inc.
$325M $9.11-1.5%
INFU
InfuSystems Holdings, Inc.
$265M $13.93-0.9%
ANIK
Anika Therapeutics Inc.
$261M $21.24+3.1%
OSUR
OraSure Technologies, Inc.
$257M $4.16+7.6%
TMCI
Treace Medical Concepts, Inc.
$253M $4.20+1.4%

CATX earnings FAQ

What is CATX's expected move for earnings?

Options currently price a move of about ±14.8%, or $0.25 per share either way from $1.69.

How does CATX stock usually react to earnings?

Across the last 2 reports the average next-day move was ±5.0%, up 2 times and down 0 times.

What is CATX's implied volatility?

CATX's at-the-money implied volatility is about 112% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in